Upcoming Events
Search Result For "Conjugates".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
The year 2024 has been considered the 'coming of age' era for antibody-drug conjugates, in great part due to the remarkable resurgence in drug deve...
Toxicities continue to pose the most significant challenge in the progression of antibody-drug conjugates to the clinic, and with increasing compan...
With numerous novel conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and m...
There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing ...
Driving Innovation in Discovery and Chemistry, Validating Clinical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads and Form...
Positioned in the goldilocks spot between small molecules and biologics, peptide therapeutics have undergone an exciting uphill trajectory within t...